Company Profile

Hebei Bailing Cell Biotechnology Co., Ltd. is a wholly-owned subsidiary of China International Cell Anti Aging Group invested in the Zhengding Free Trade Zone in Hebei Province. It focuses on the storage of human immune cells and stem cells, cell health management, chronic disease regulation, sub-health management, anti-aging technology research and development, and clinical application. We provide customers with customized and exclusive health solutions in all aspects. The company has a number of international leading technologies, especially in the fields of stem cell intervention in gradually frozen people, children's cerebral palsy, autism, Alzheimer's disease, Parkinson's disease, diabetes, diabetes complications, osteoarthritis, multiple plasma cell granuloma, liver ascites, early and middle cirrhosis, pulmonary nodules, pulmonary fibrosis, asthma, early and middle tumors, etc.
The company's affiliated group has strong strength, with 6 holding subsidiaries and 5 high-end obstetrics and gynecology hospitals. In 2021, the group invested heavily to establish its own proprietary centenarian cell industry building and stem cell rehabilitation hospital in the Zhengding area of the Hebei Free Trade Zone in China, and obtained joint approval from three major departments of the country's first free trade zone for the "Tissue Cell Bank and Stem Cell Preparation Clinical Application Research Center" with a red headed document. In 2022, the enterprise was approved to establish the president unit of Cell Research and Application Branch of China Anti aging Promotion Association, and officially signed a contract with PICC to underwrite the company's entire range of products and protect consumers. In 2023, we will collaborate with Peking University to establish a joint laboratory for mesenchymal stem cell therapy research and a doctoral workstation in biomedical engineering at Peking University. In July of the same year, it was awarded the title of "Top 10 Influential Brands in the Stem Cell Industry in 2023" at the Great Hall of the People. The company has been recognized and valued by the leaders of Hebei Province, and has been visited, inspected, and guided by provincial leaders multiple times. The Group has set up stem cell project operation centers in the three major free trade zones of Hebei, Beijing and Hainan Boao, and its business has spread throughout major regions of the country and gradually extended to overseas countries along the the Belt and Road.
The company's mission is to improve the quality of life and promote healthy aging. It fully leverages the role of the national system innovation "experimental field" in the pilot free trade zone, establishes three major platforms: the "Aging Engineering Cell Life Bank", the "China International Stem Cell Research Institute", and the "Aging Stem Cell Life Science and Technology Museum", and constructs a complete industry service chain integrating cell technology research and development, achievement transformation, disease intervention, industry exchange, and popular science popularization. It maximizes the satisfaction of the public's different needs for biotechnology industry services and is committed to becoming a leader in the gene cell health industry and a guide in the standardization system.